Literature DB >> 3098186

Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.

M M Brett, A T Ghoneim, J M Littlewood.   

Abstract

Serum IgG antibodies to Pseudomonas aeruginosa cell surface antigens were determined by enzyme linked immunosorbent assay. Titres in patients without cystic fibrosis were low (140-235). Those in patients with cystic fibrosis who were chronically infected by P. aeruginosa were very high (1100-20,500), while patients who grew the organism intermittently had lower titres (160-4400). Longitudinal studies showed that raised titres were observed at a very early stage of infection. High titres were associated with a poor clinical state, while low titres were associated with a better clinical state in both chronic and intermittently infected patients with cystic fibrosis. These results suggest that this test is a specific and sensitive measure of the severity and progress of the different stages of pulmonary infection by P. aeruginosa in patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098186      PMCID: PMC1778111          DOI: 10.1136/adc.61.11.1114

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

2.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

3.  The systematic evaluation of the chest radiograph in cystic fibrosis.

Authors:  A R Chrispin; A P Norman
Journal:  Pediatr Radiol       Date:  1974

4.  Monoclonal antibodies against Pseudomonas aeruginosa outer membrane antigens: isolation and characterization.

Authors:  R E Hancock; A A Wieczorek; L M Mutharia; K Poole
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

5.  Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

6.  Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.

Authors:  R E Hancock; E C Mouat; D P Speert
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

7.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.

Authors:  N Hoiby; E W Flensborg; B Beck; B Friis; S V Jacobsen; L Jacobsen
Journal:  Scand J Respir Dis       Date:  1977-04

9.  Measurement of human antibody activity against Escherichia coli and Pseudomonas aeruginosa using formalin treated whole organisms in an ELISA technique.

Authors:  K M Cost; C S West; D Brinson; H C Polk
Journal:  J Immunoassay       Date:  1985
  9 in total
  22 in total

1.  Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.

Authors:  M M Brett; A T Ghoneim; J M Littlewood
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

2.  Pseudomonas infections in cystic fibrosis.

Authors:  R H George
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

3.  Serum IgG antibodies to Pseudomonas aeruginosa in intensive care adult patients.

Authors:  R Cohendy; B Perrin; J L Vaille; H Mion
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

4.  Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay.

Authors:  S S Pedersen; F Espersen; N Høiby
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

5.  Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  A Fomsgaard; B Dinesen; G H Shand; T Pressler; N Høiby
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

6.  Antibody response of fibrocystic patients to homologous 0-typable and 0-defective isolates of Pseudomonas aeruginosa.

Authors:  J MacDougall; M E Hodson; T L Pitt
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

7.  Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.

Authors:  A Brauner; S J Cryz; M Granström; H S Hanson; L Löfstrand; B Strandvik; B Wretlind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

8.  Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study.

Authors:  M M Brett; A T Ghoneim; J M Littlewood
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

9.  Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis.

Authors:  K de Boeck; E Eggermont; M Smet; P van Reempts; H P van Bever; W J Stevens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

10.  A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.

Authors:  M L Dunkley; R L Clancy; A W Cripps
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.